Last updated: 6 July 2019 at 1:47am EST

Jeffrey K Tobias Net Worth




The estimated Net Worth of Jeffrey K Tobias is at least $6.12 Миллион dollars as of 10 February 2015. Jeffrey Tobias owns over 5,000 units of Jazz Pharmaceuticals plc stock worth over $4,211,823 and over the last 12 years Jeffrey sold JAZZ stock worth over $1,905,182.

Jeffrey Tobias JAZZ stock SEC Form 4 insiders trading

Jeffrey has made over 17 trades of the Jazz Pharmaceuticals plc stock since 2013, according to the Form 4 filled with the SEC. Most recently Jeffrey exercised 5,000 units of JAZZ stock worth $234,150 on 10 February 2015.

The largest trade Jeffrey's ever made was exercising 7,500 units of Jazz Pharmaceuticals plc stock on 9 August 2013 worth over $351,225. On average, Jeffrey trades about 2,468 units every 25 days since 2012. As of 10 February 2015 Jeffrey still owns at least 40,063 units of Jazz Pharmaceuticals plc stock.

You can see the complete history of Jeffrey Tobias stock trades at the bottom of the page.



What's Jeffrey Tobias's mailing address?

Jeffrey's mailing address filed with the SEC is C/O JAZZ PHARMACEUTICALS PLC, CONNAUGHT HOUSE, 1 BURLINGTON RD, FL. 4, DUBLIN 4, L2, .

Insiders trading at Jazz Pharmaceuticals plc

Over the last 17 years, insiders at Jazz Pharmaceuticals plc have traded over $1,513,676,247 worth of Jazz Pharmaceuticals plc stock and bought 1,319,315 units worth $25,188,964 . The most active insiders traders include Michael W Michelson, Patrick G Enright и Jp Iii Llckkr Partners Iii,.... On average, Jazz Pharmaceuticals plc executives and independent directors trade stock every 11 days with the average trade being worth of $5,162,934. The most recent stock trade was executed by Mary Elizabeth Henderson on 6 September 2024, trading 1,410 units of JAZZ stock currently worth $152,703.



What does Jazz Pharmaceuticals plc do?

jazz pharmaceuticals plc (nasdaq: jazz) is an international biopharmaceutical company focused on improving patients’ lives by identifying, developing and commercializing meaningful products that address unmet medical needs. we are a diverse company of over 875 employees focused on portfolio of products and/or product candidates in the areas of sleep, hematology/oncology and pain. founded in 2003 and headquartered in dublin, ireland, jazz pharmaceuticals has u.s. offices in palo alto, ca and philadelphia, pa, and has offices in various other locations in europe. the company’s maintains a highly collaborative and entrepreneurial culture where employees focus on how they accomplish success as well as what is done to accomplish results by operating in accordance with the company’s core values: integrity, collaboration, passion, innovation and the pursuit of excellence. we plan to build upon our portfolio of products through acquisition and/or in-licensing activities, and leveraging our uni



Complete history of Jeffrey Tobias stock trades at Jazz Pharmaceuticals plc

инсайдер
Транзакция
Транзакция
Общая стоимость
Jeffrey K Tobias
Исполнительный вице-президент, Research, Dev и CMO
Реализация опциона $234,150
10 Feb 2015
Jeffrey K Tobias
Исполнительный вице-президент, Research, Dev и CMO
Продажа $782,212
24 Nov 2014
Jeffrey K Tobias
Исполнительный вице-президент, Research, Dev и CMO
Продажа $173,320
14 Nov 2014
Jeffrey K Tobias
Исполнительный вице-президент, Research, Dev и CMO
Продажа $154,040
10 Oct 2014
Jeffrey K Tobias
Исполнительный вице-президент, Research, Dev и CMO
Продажа $171,220
12 Sep 2014
Jeffrey K Tobias
Исполнительный вице-президент, Research, Dev и CMO
Реализация опциона $260,166
11 Aug 2014
Jeffrey K Tobias
Исполнительный вице-президент, Research, Dev и CMO
Реализация опциона $145,890
9 Jun 2014
Jeffrey K Tobias
Исполнительный вице-президент, Research, Dev и CMO
Продажа $128,010
16 May 2014
Jeffrey K Tobias
Исполнительный вице-президент, Research, Dev и CMO
Реализация опциона $161,640
14 Apr 2014
Jeffrey K Tobias
Исполнительный вице-президент, Research, Dev и CMO
Реализация опциона $161,640
10 Mar 2014
Jeffrey K Tobias
Исполнительный вице-президент, Research, Dev и CMO
Продажа $496,380
27 Feb 2014
Jeffrey K Tobias
Исполнительный вице-президент, Research, Dev и CMO
Реализация опциона $119,885
10 Feb 2014
Jeffrey K Tobias
Исполнительный вице-президент, Research, Dev и CMO
Реализация опциона $62,050
9 Dec 2013
Jeffrey K Tobias
Исполнительный вице-президент, Research, Dev и CMO
Реализация опциона $111,128
11 Nov 2013
Jeffrey K Tobias
Исполнительный вице-президент, Research, Dev и CMO
Реализация опциона $234,150
14 Oct 2013
Jeffrey K Tobias
Исполнительный вице-президент, Research, Dev и CMO
Реализация опциона $234,150
9 Sep 2013
Jeffrey K Tobias
Исполнительный вице-президент, Research, Dev и CMO
Реализация опциона $351,225
9 Aug 2013


Jazz Pharmaceuticals plc executives and stock owners

Jazz Pharmaceuticals plc executives and other stock owners filed with the SEC include: